StockData
Evofem Biosciences, Inc. logo

Evofem Biosciences, Inc. (EVFM) stock

EVFMOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 1/30
$0.01−0.00 (-10.00%)

Close on Oct 19, 2026Market cap $865.23KP/E –Yield –

Evofem Biosciences EV/EBITDA

EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.

Evofem Biosciences's EV/EBITDA was 0.1× on Apr 30, 2026.

EV/EBITDA at the end of each year

PeriodPeriod endValueChange (pts)
2026Apr 30, 20260.1×–

More Evofem Biosciences figures

See a number that looks wrong?